International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
An international coalition sequenced the full genome of an Australian pitcher plant and compared it to both carnivorous and non-carnivorous plants.
BGI will start offering quantitative RNA-seq services on the BGISEQ-500 soon, followed by whole-genome sequencing later this year.
This week's news includes Ambry Genetics, DNAstack, Protea Biosciences Group, Exosome Diagnostics, BGI Europe, and Castle Biosciences.
Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.
The research used multiple genetic analyses on samples collected over 29 years to show changes associated with disease progression.
The new division will enable BGI to expand partnerships with universities, companies, and health and agriculture-related organizations, among other things.
The study is the first published data of BGI's desktop sequencer, BGISEQ-500, which German researchers are studying for use in evaluating microRNA biomarkers.
The researchers reported that about three quarters of the 10-gigabase ginkgo genome consists of repeat sequences.
The new BGISEQ-50, a smaller version of the BGISEQ-500, will have research and clinical applications, and BGI plans to register it with the CFDA, too.
23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.
By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.